Clinical Trial Update: Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating bezafibrate combined with ursodeoxycholic acid in primary biliary cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• Bezafibrate (bezafibrate)
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: PBC | Phase 3 | Status: COMPLETED